| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $203K | +0.0% |
| SG&A Expense | $4.0M | -56.1% |
| Operating Income | -$4.0M | +96.4% |
| Pre-tax Income | -$2.2M | +98.0% |
| Income Tax | $0 | — |
| Net Income | -$18.5M | +87.6% |
| EPS (Basic) | -$4.77 | +87.7% |
| EPS (Diluted) | -$4.77 | +87.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $501K | +117.6% |
| Current Assets | $10.3M | -9.0% |
| Total Assets | $10.3M | -69.6% |
| Current Liabilities | $8.7M | -46.0% |
| Long-term Debt | $4.1M | +26.6% |
| Total Liabilities | $12.2M | -32.9% |
| Stockholders' Equity | -$1.9M | -111.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.7M | +37.0% |
| Capital Expenditures | $2.9M | +0.0% |
| Investing Cash Flow | $7.1M | -5.7% |
| Financing Cash Flow | $1.9M | +170.3% |
| Free Cash Flow | -$11.7M | +30.5% |